|1.||Pasquali, G: 1 article (01/2014)|
|2.||La Torre, R: 1 article (01/2014)|
|3.||Bevilacqua, E: 1 article (01/2014)|
|4.||Perrone, G: 1 article (01/2014)|
|5.||Aliberti, C: 1 article (01/2014)|
|6.||D'Ambrosio, V: 1 article (01/2014)|
|7.||Giancotti, A: 1 article (01/2014)|
|8.||Willruth, Arne: 1 article (06/2012)|
|9.||Lorenzen, Henning: 1 article (06/2012)|
|10.||Gembruch, Ulrich: 1 article (06/2012)|
10/01/1989 - "2 recent studies have demonstrated that a regimen of a single oral dose of 600 mg of mifepristone (RU-486) followed 48 hours later by a 1 mg gemeprost pessary will induce complete abortion in over 95% of women with amenorrhea of less than 56 days' duration. "
10/01/1991 - " 90 primigravid women with 63-91 days of amenorrhea and ultrasonically confirmed single living fetus of correct size for gestational age were included; women were allocated to receive 200 mg mifepristone orally or an identical oral placebo 36 hours before their operation of 1 mg gemeprost vaginal pessary 3-4 hours preoperatively. "
12/14/1990 - " In a British multicenter study, the combination of RU-486 and intravaginal gemeprost induced abortion in 95% of 600 women with up to 63 days of amenorrhea. "
05/01/1989 - " To test the efficacy and side effects of these drugs when used in combination, 120 women of less than 56 days amenorrhea received a single 600 mg dose of mifepristone and 48 hours later 1/2 or 1 mg of the prostaglandin gemeprost administered in vaginal pessary form. "
12/14/1990 - " In a multicenter study carried out in France, 1 600-mg dose of RU-486, followed 36-48 hours later by intramuscular sulprostone or intravaginal gemeprost, induced complete abortion in 96% of 2000 women with up to 49 days of amenorrhea. "
|2.||Spontaneous Abortion (Miscarriage)
08/01/1994 - "The purpose of this study was to determine the efficacy of a medical approach to the management of spontaneous abortion using the prostaglandin analogue, gemeprost. "
09/01/1995 - "Retrospective comparison of histological features in fetuses aborted following maternal administration of gemeprost, with those in fetuses after spontaneous miscarriage. "
01/01/2014 - "A case of uterine rupture in mid-trimester spontaneous abortion: a complication of gemeprost vaginal administration."
01/01/2006 - "There was no statistically significant difference between vaginal misoprostol and gemeprost in the induction of miscarriage for fetal death after 13 weeks. "
04/09/2001 - "A prospective, randomised study was carried out to clarify the effect of vaginal administration of a prostaglandin E1 analogue (gemeprost) versus surgical management (curettage) of miscarriages at up to twelve weeks of gestation. "
05/31/1999 - "Half of the women began to bleed before application of gemeprost, and 91% had bleeding for more than six days. "
01/01/1999 - "All patients who were treated with rectally administered gemeprost pessaries had cessation of bleeding per vaginum. "
03/01/2007 - "The study was conducted to determine whether placenta previa increases bleeding during gemeprost-induced termination of second-trimester pregnancy. "
01/01/1999 - "Per vaginum bleeding with continued postpartum hemorrhage; adverse patient reactions to gemeprost; need for operative intervention. "
10/23/1992 - "Gemeprost produces an increase in uterine contractility which may be additional to cervical softening properties and which may be responsible for the adverse effects of pain and bleeding experienced by some women prior to termination."
03/01/2005 - "The regimen of gemeprost proposed seems to be as safe and effective in patients with uterine scars as in women with unscarred uteri with a very low incidence of complications."
06/01/2012 - "Second- and third-trimester termination of pregnancy in women with uterine scar - a retrospective analysis of 111 gemeprost-induced terminations of pregnancy after previous cesarean delivery."
03/01/2005 - "A short-scheme protocol of gemeprost for midtrimester termination of pregnancy with uterine scar."
06/01/2012 - "This study was conducted to evaluate and analyze the efficacy and safety of using gemeprost for second- and third-trimester termination of pregnancy (TOP) in women with uterine scar due to previous cesarean section. "
06/01/2012 - "Gemeprost-induced TOP in the second and third trimester in women with uterine scar due to previous cesarean section is effective and has a low complication rate."
05/31/1999 - "Four of 100 women were evacuated: one due to severe vaginal bleeding four hours after application of gemeprost, two because of womiting soon after having taken RU486 and one due to incomplete abortion. "
06/01/1995 - " This study confirms the efficacy of the lower dose of mifepristone and further indicates the feasibility of a reduction in the gemeprost dose from the standard 1 mg to 0.5 mg. To reduce the rate of incomplete abortion associated with this procedure, it is recommended that misoprostol not be used in women with 49 or more days of amenorrhea."
|2.||Mifepristone (RU 486)
|5.||Analgesics (Analgesic Drugs)
|7.||Suppositories (Vaginal Suppositories)
|4.||Cesarean Section (Caesarean Section)
|5.||Induced Abortion (Induced Abortions)